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LETTERS
Cutaneous
Leishmaniasis,
Northern
Afghanistan 
To the Editor: In Afghanistan,
most cutaneous leishmaniasis cases
are caused by Leishmania tropica,
which is transmitted anthroponotical-
ly by the sandfly Phlebotomus sergen-
ti (1). Cutaneous leishmaniasis can
have devastating effects on local com-
munities because of its clinical symp-
toms, i.e., large, multiple, or both, dis-
figuring lesions, that can lead to social
ostracism of affected persons (e.g.,
women are often deemed unsuitable
for marriage or to raise children) (2).
Cutaneous leishmaniasis is consid-
ered a low priority disease by interna-
tional donor agencies because treat-
ment costs are high and the disease
does not cause death (3).
Data on the effects of cutaneous
leishmaniasis in Afghanistan previ-
ously have been available only for
Kabul city; recent studies have report-
ed an estimated 67,500 cases (4).
Because of the migration of an esti-
mated 4.5 million infected Afghan
refugees returning home from other
countries, the sporadic treatment of
patients infected with cutaneous leish-
maniasis, and limited control of the
sandfly vector, L. tropica has spread
to areas that were previously nonen-
demic for the disease, e.g., northeast-
ern Afghanistan.
A survey in Faizabad city,
Badakhshan Province, was conducted
in June 2003 by HealthNet
International to collect data on the
impact of cutaneous leishmaniasis.
Leishmaniasis in this region is trans-
mitted from April to October. The city
was divided into 10 districts, and 20
households were surveyed along a
randomly chosen transect drawn from
the center of each district. A team of
experienced medical staff clinically
diagnosed cutaneous leishmaniasis
(based on the presence or absence of
cutaneous leishmaniasis lesions or
scars, number of lesions, date of
lesion onset) in household members
and interviewed them to collect
demographic data (gender, age).
Because of logistic constraints, para-
sitologic diagnosis of cutaneous leish-
maniasis lesions (i.e., microscopic
examination or parasite culture) was
not conducted. However, in
Afghanistan, skin lesions attributed to
causes other than cutaneous leishma-
niasis are rare, and experience has
shown that clinical diagnosis has a
sensitivity and specificity of >80%
and >90%, respectively (Reithinger et
al., unpub. data). Written approval to
conduct the study was obtained from
the Ministry of Health. Informed con-
sent was obtained from study partici-
pants; all study participants with
active cases of the disease were
offered free anti-leishmanial treat-
ment at the HealthNet International
leishmaniasis clinic.
We surveyed 1,832 people from
200 households; 8.3% (152/1,832)
and 7.8% (142/1,832) had active cuta-
neous leishmaniasis lesions or scars,
respectively. Of those persons with
cutaneous leishmaniasis lesions, the
mean lesion number was 2.4 (range
1–14), the mean lesion size was 2.4
cm (range 1–5.5), and the mean lesion
duration (to survey date) was 5.6
months (range 1–11). Active preva-
lence was not associated with gender
(Yates-corrected χ2 = 2.16, p = 0.14);
85/152 (56%) of the cutaneous leish-
maniasis case-patients were women,
and 67/152 (44%) of cutaneous leish-
maniasis case-patients were men.
Data showed that persons aged ≤15
years were at higher risk of contract-
ing the disease than were persons
aged >15 years (odds ratio = 2.23,
95% CI 1.54 to 3.24, Yates-corrected
χ2 = 19.44, p < 0.001). 
Based on population estimates of
65,000 people and observed preva-
lence, approximately 5,395 cutaneous
leishmaniasis case-patients would be
found in Faizabad. The low preva-
lence of scars, compared to the high
prevalence of disease, shows that
cutaneous leishmaniasis has been
introduced into Faizabad only recent-
ly (1,4). Local Ministry of Health
records show that the disease was vir-
tually absent (<50 annual cases) in
Badakhshan 3 years ago; this infor-
mation is corroborated by the obser-
vation that the mean time since the
recovery of surveyed people with
cutaneous leishmaniasis scars was 1.5
years (range 0.3–15). Although no
attempts were made to identify circu-
lating Leishmania sp., the current epi-
demic is likely caused by L. tropica
because both men and women are
equally affected and younger age
groups are at higher risk for cutaneous
leishmaniasis than older age groups
(1,4). Current analyses are under way
to establish risk factors (e.g., presence
or absence of animals, type of house
construction) for contracting the dis-
ease.
With support from HealthNet
International, three leishmaniasis clin-
ics have been established in Faizabad
to increase the total number of
patients whose illness is diagnosed
and treated; to reduce the risk to sus-
ceptible persons through the subsi-
dized sale of insecticide-impregnated
bed nets; to train and supervise the
Ministry of Health staff in diagnosis,
treatment, and prevention of the dis-
ease; and to implement health educa-
tion campaigns for patients attending
the clinics and the community at
large. Hopefully, these activities will
prevent the current cutaneous leish-
maniasis outbreak from becoming an
epidemic, as it has been in Kabul over
the past 15 years (4,5).
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Rickettsia felis,
Bartonella 
henselae, and 
B. clarridgeiae,
New Zealand
To the Editor: The cat flea
(Ctenocephalides felis felis Bouché,
1935) is a ubiquitous parasite of
domestic and wild animals that also
feeds readily on people. Recent stud-
ies have implicated the cat flea as a
vector of new and emerging infectious
diseases (1). To determine the
pathogens in C. felis in New Zealand,
we collected 3 cat fleas from each of
11 dogs and 21 cats at the Massey
University Veterinary Teaching
Hospital from May to June 2003. The
fleas were stored in 95% alcohol until
they were identified by using morpho-
logic criteria and washed in sterile
phosphate-buffered saline. The DNA
from each flea was extracted individ-
ually by using the QiaAmp Tissue Kit
(QIAGEN Ltd., Hilden, Germany),
according to the manufacturer’s
instructions. When polymerase chain
reaction (PCR) was performed with
primers for gltA and rOmpA as
described (2), products were obtained
with DNA from 15 (15%) of the fleas.
The sequences of the products were
identical to those of Rickettsia felis
(GenBank AF191026) with infected
fleas taken from both dogs (3/11;
27%) and cats (7/21; 33%). When
PCR was performed with primers for
the 16S-23S rDNA interspacer region
as described (3), products were
obtained with DNA of four fleas. The
sequences of the products from three
fleas (from two cats) were identical to
that of Bartonella henselae (GenBank
AF312495), and the sequence of the
product of one flea (from a cat) was
identical to that of B. clarridgeiae
(GenBank AF167989). 
Our study is the first to identify R.
felis in Oceania. The organism is a
recently described human pathogen,
and infections with this spotted fever
group rickettsia have already been
reported in 11 persons: 4 persons in
the United States, 2 persons in Brazil,
4 persons in Europe, and 1 person in
Thailand. The symptoms of the
patients were nonspecific and includ-
ed fever, headache, and rash.
Diagnoses were made by sequencing
products obtained by PCR with
primers for the 17-kDa protein (4),
citrate synthase (4), and PS 120 pro-
tein (5) genes. R. felis has been estab-
lished in tissue culture (XTC-2 and
Vero cells) (6), and serologic testing
has been used to diagnose infections
(5). Reports indicate that patients
respond rapidly to doxycycline thera-
py (5), and in vitro studies have
shown the organism is susceptible to
rifampin, thiamphenicol, and fluoro-
quinolones. 
B. henselae is an agent of cat-
scratch disease, bacillary angiomato-
sis, bacillary peliosis, endocarditis,
bacteremia, and various neurologic
and ocular conditions. Cats are the
reservoir hosts, and contact with cats
and their fleas is an established risk
factor for most infections. Although
B. henselae has been isolated from
17% of domestic cats in New Zealand
(7), only two human infections have
been reported in the country; neurore-
tinitis was diagnosed in both patients
(8). In neighboring Australia, howev-
er, cat-scratch disease, bacillary
angiomatosis, and endocarditis have
been diagnosed in numerous patients.
Cats are also the reservoir hosts of B.
clarridgeiae which has been implicat-
ed as an agent of cat-scratch disease in
humans and aortic valve endocarditis
and hepatic disease in dogs (9). The
organism has been found in cat fleas
(as great as 17%) in Europe (1), and
although we found only one flea
infected with B. clarridgeiae in New
Zealand, this description is the first of
the organism in Oceania. However, B.
clarridgeiae has been found in
domestic cats in nearby Indonesia and
the Philippines (10). 
Our findings add to the accumulat-
ing data on R. felis, B. henselae, and
B. clarridgeiae and should alert med-
ical workers in New Zealand, a com-
mon tourist destination, to the possi-
bility that their patients may be infect-
ed with these organisms. 
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